Đánh giá các nhóm dưới của chiến lược cấp phát nhiều tháng cho chăm sóc HIV khác biệt: Liệu việc cá nhân hóa các hướng dẫn chăm sóc có cần thiết ở Haiti?
Tóm tắt
Từ khóa
Tài liệu tham khảo
Grimsrud A, Bygrave H, Doherty M, Ehrenkranz P, Ellman T, Ferris R, et al. Reimagining HIV service delivery: the role of differentiated care from prevention to suppression: the. J Int AIDS Soc. 2016;19(1):10–2.
Grimsrud A, Barnabas RV, Ehrenkranz P, Ford N. Evidence for scale up: The differentiated care research agenda. J Int AIDS Soc. 2017;20(00):1–6. https://doi.org/10.7448/IAS.20.5.22024.
Duncombe C, Rosenblum S, Hellmann N, Holmes C, Wilkinson L, Biot M, et al. Reframing HIV care: putting people at the Centre of antiretroviral delivery. Trop Med Int Heal. 2015;20(4):430–47.
Mutasa-Apollo T, Ford N, Wiens M, Socias ME, Negussie E, Wu P, et al. Effect of frequency of clinic visits and medication pick-up antiretroviral therapy outcomes: a systematic review and meta-analysis. J Int AIDS Soc. 2017;20(Suppl 4):21647 Available from: http://www.jiasociety.org/index.php/jias/article/view/21647.
Fatti G, Ngorima-Mabhena N, Mothibi E, Muzenda T, Choto R, Kasu T, et al. Outcomes of three- versus six-monthly dispensing of antiretroviral treatment (ART) for stable HIV patients in community ART refill groups: a cluster-randomized trial in Zimbabwe. J Acquir Immune Defic Syndr. 2020;84(2):162–72.
National HIV Control Program. Haiti HIV Treatment Guidelines. 2016.
Parrish C, Basu A, Fishman P, Koama JB, Robin E, Francois K, et al. Estimating the effect of increasing dispensing intervals on retention in care for people with HIV in Haiti. EClinicalMedicine. 2021;38:101039.
Green L, Glasgow R, Atkins D, Stange K. Making evidence from research more relevant, useful, and actionable in policy, program planning, and practice. Am J Prev Med. 2009;37(6):S187–91. https://doi.org/10.1016/j.amepre.2009.08.017.
Angrist JD, Imbens GW, Rubin DB, Angrist JD, Imbens GW, Rubin DB. Identification of causal effects using instrumental variables linked references are available on JSTOR for this article : identification of causal effects using instrumental variables. J Am Stat Assoc. 1996;91(434):444–55.
Basu A, Heckman JJ, Navarro-lozano S, Urzua S. Use of instrumental variables in the presence of heterogeneity and self-selection : an application to treatments of breast cancer patients. Health Econ. 2007;1157(October):1133–57.
Hayes AF, Rockwood NJ. Behaviour Research and Therapy Regression-based statistical mediation and moderation analysis in clinical research : Observations , recommendations , and implementation. Behav Res Ther. 2017;98, 39:–57. https://doi.org/10.1016/j.brat.2016.11.001.
Thompson SG, Higgins JPT. How should meta-regression analyses be undertaken and interpreted ? Stat Med. 2002;1573:1559–73.
Redelmeier DA, Shafir E. Medical Decision Making in Situations That Offer Multiple Alternatives. JAMA. 1995;273(4).
Rabkin M, El-Sadr WM. Why reinvent the wheel? Leveraging the lessons of HIV scale-up to confront non-communicable diseases. Glob Public Health. 2011;6(3):247–56.
Kruk ME, Gage AD, Joseph NT, Danaei G, García-Saisó S, Salomon JA. Mortality due to low-quality health systems in the universal health coverage era: a systematic analysis of amenable deaths in 137 countries. Lancet. 2018;392(10160):2203–12.
Brookes ST, Whitely E, Egger M, Davey G, Mulheran PA, Peters TJ. Subgroup analyses in randomized trials : risks of subgroup-specific analyses ; power and sample size for the interaction test. J Clin Epidemiol. 2004;57:229–36.
Rothwell PM. Subgroup analysis in randomised controlled trials: importance, indications, and interpretation. Lancet. 2005;365.
Puttkammer N, Domerçant JW, Adler M, Yuhas K, Myrtil M, Young P, et al. ART attrition and risk factors among option B+ patients in Haiti: a retrospective cohort study. PLoS One. 2017;12(3):1–14.
Deriel E, Puttkammer N, Hyppolite N, Diallo J, Wagner S, Honoré JG, et al. Success factors for implementing and sustaining a mature electronic medical record in a low-resource setting: A case study of iSanté in Haiti. Health Policy Plan. 2018;33(2):237–46 Available from: https://academic.oup.com/heapol/article/33/2/237/4745760. [cited 2021 Nov 4].
Matheson AI, Baseman JG, Wagner SH, O’Malley GE, Puttkammer NH, Emmanuel E, et al. Implementation and expansion of an electronic medical record for HIV care and treatment in Haiti: an assessment of system use and the impact of large-scale disruptions. Int J Med Inform. 2012;81(4):244–56. https://doi.org/10.1016/j.ijmedinf.2012.01.011.
Lober WB, Quiles C, Wagner S, et al. Three years experience with the implementation of a networked electronic medical record in Haiti. AMIA Annu Symp Proc. 2008;2008:434–8. Accessed 12 Jul 2021. /pmc/articles/PMC2655963/.
Margolis AM, Heverling H, Pham PA, Stolbach A. A review of the toxicity of HIV medications. J Med Toxicol. 2014;10(1):26–39.
World Health Organization. WHO Case Definitions of HIV for Surveillance and Revised Clinical Staging and Immunological Classification of HIV-Related Disease in Adults and Children; 2007. https://apps.who.int/iris/bitstream/handle/10665/43699/9789241595629_eng.pdf.
Tibshirani R. Regression shrinkage and selection via the lasso. J R Stat Soc. 1996;58(1):267–88.
Urminsky O, Hansen C, Chernozhukov V. Using double-lasso regression for principled variable selection. SSRN. 2016;2733374.
Terza JV, Basu A, Rathouz PJ. Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling. J Health Econ. 2008;27(3):531–43.
Tibshirani R. The lasso method for variable selection in the Cox model. Stat Med. 1997;16(4):385–95.
Chan M, Kazatchkine M, Lob-levyt J, Obaid T, Schweizer J, Veneman A, et al. Meeting the demand for results and Accountability : a call for action on health data from eight Global Health agencies. PLOS. 2010;7(1):5–8.
PEPFAR. Haiti Country Operational Plan COP 2016 Strategic Direction Summary. 2016.
Prust ML, Banda CK, Nyirenda R, et al. Multi-month prescriptions, fast-track refills, and community ART groups: Results from a process evaluation in Malawi on using differentiated models of care to achieve national HIV treatment goals. J Int AIDS Soc. 2017;20(Suppl 4):41–50. https://doi.org/10.7448/IAS.20.5.21650.
Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, et al. Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA task force report. Value Heal. 2005;8(5):521–33. https://doi.org/10.1111/j.1524-4733.2005.00045.x.
O’Sullivan AK, Thompson D, Drummond MF. Collection of health-economic data alongside clinical trials: is there a future for piggyback evaluations? Value Heal. 2005;8(1):67–79. https://doi.org/10.1111/j.1524-4733.2005.03065.x.
World Health Organization. WHO: access to HIV medicines severely impacted by COVID-19 as AIDS response stalls. 2020. Available from: https://www.who.int/news-room/detail/06-07-2020-who-access-to-hiv-medicines-severely-impacted-by-covid-19-as-aids-response-stalls
UNAIDS. UNAIDS Fast Track Targets. 2014. Available from: http://www.unaids.org/sites/default/files/media_asset/JC2686_WAD2014report_en.pdf
Papworth E, Grosso A, Ketende S, Wirtz A, Cange C, Kennedy C, Baral S. Examining risk factors for HIV and access to services among female sex workers (FSW) and men who have sex with men (MSM) in Burkina Faso, Togo and Cameroon. Baltimore: USAID: Project Search: Research to Prevention; 2014.